phosphatidylinositol-4-phosphate and Cell-Transformation--Neoplastic

phosphatidylinositol-4-phosphate has been researched along with Cell-Transformation--Neoplastic* in 2 studies

Reviews

1 review(s) available for phosphatidylinositol-4-phosphate and Cell-Transformation--Neoplastic

ArticleYear
GOLPH3 and oncogenesis: What is the molecular link?
    Tissue & cell, 2017, Volume: 49, Issue:2 Pt A

    The Golgi phosphoprotein 3 (GOLPH3) is encoded by a gene that is located in a region of the human genome that is often amplified in different solid tumours. GOLPH3, an evolutionary conserved phosphatidylinositol 4-phosphate (PI4P) binding protein, is mainly localised at trans Golgi network (TGN). It regulates several cellular functions like Golgi vesicular trafficking, Golgi glycosylation and mitochondrial cardiolipin production. Recently, GOLPH3 was discovered to be part of the DNA damage response signalling pathway, with a role in cell survival following DNA damage. In this review, we will explore the cellular functions regulated by GOLPH3 and discuss if and how they contribute to the oncogenic activity of this intriguing Golgi localized oncoprotein.

    Topics: Amino Acid Sequence; Carcinogenesis; Cell Transformation, Neoplastic; DNA Damage; Golgi Apparatus; Humans; Membrane Proteins; Phosphatidylinositol Phosphates; Protein Transport; trans-Golgi Network

2017

Other Studies

1 other study(ies) available for phosphatidylinositol-4-phosphate and Cell-Transformation--Neoplastic

ArticleYear
Distinct Biochemical Pools of Golgi Phosphoprotein 3 in the Human Breast Cancer Cell Lines MCF7 and MDA-MB-231.
    PloS one, 2016, Volume: 11, Issue:4

    Golgi phosphoprotein 3 (GOLPH3) has been implicated in the development of carcinomas in many human tissues, and is currently considered a bona fide oncoprotein. Importantly, several tumor types show overexpression of GOLPH3, which is associated with tumor progress and poor prognosis. However, the underlying molecular mechanisms that connect GOLPH3 function with tumorigenicity are poorly understood. Experimental evidence shows that depletion of GOLPH3 abolishes transformation and proliferation of tumor cells in GOLPH3-overexpressing cell lines. Conversely, GOLPH3 overexpression drives transformation of primary cell lines and enhances mouse xenograft tumor growth in vivo. This evidence suggests that overexpression of GOLPH3 could result in distinct features of GOLPH3 in tumor cells compared to that of non-tumorigenic cells. GOLPH3 is a peripheral membrane protein mostly localized at the trans-Golgi network, and its association with Golgi membranes depends on binding to phosphatidylinositol-4-phosphate. GOLPH3 is also contained in a large cytosolic pool that rapidly exchanges with Golgi-associated pools. GOLPH3 has also been observed associated with vesicles and tubules arising from the Golgi, as well as other cellular compartments, and hence it has been implicated in several membrane trafficking events. Whether these and other features are typical to all different types of cells is unknown. Moreover, it remains undetermined how GOLPH3 acts as an oncoprotein at the Golgi. Therefore, to better understand the roles of GOLPH3 in cancer cells, we sought to compare some of its biochemical and cellular properties in the human breast cancer cell lines MCF7 and MDA-MB-231 with that of the non-tumorigenic breast human cell line MCF 10A. We found unexpected differences that support the notion that in different cancer cells, overexpression of GOLPH3 functions in diverse fashions, which may influence specific tumorigenic phenotypes.

    Topics: 1-Phosphatidylinositol 4-Kinase; Animals; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Cyclin-Dependent Kinase Inhibitor Proteins; Female; HeLa Cells; Humans; MCF-7 Cells; Membrane Proteins; Mice; Neoplasm Transplantation; Phosphatidylinositol Phosphates; Rats; trans-Golgi Network; Transplantation, Heterologous

2016